Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.

There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can help researchers identify new antimicrobials.

Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could accelerate

These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

A newly discovered planet that should be too big to have formed around a tiny star is throwing into question what researchers know about planet formation.

The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced

Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease.

A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.